Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
West China Hospital
State University of New York at Buffalo
M.D. Anderson Cancer Center
Mayo Clinic
Jonsson Comprehensive Cancer Center
Roswell Park Cancer Institute
University of California, Davis
Beth Israel Deaconess Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
University of California, San Diego
University of Iowa
University of Pittsburgh
Fox Chase Cancer Center
University of Michigan Rogel Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NuCana plc
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Memorial Sloan Kettering Cancer Center
University of California, Davis
Rabin Medical Center
University of Colorado, Denver
Sarcoma Oncology Research Center, LLC
University Hospital, Antwerp
M.D. Anderson Cancer Center
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Peking University Cancer Hospital & Institute
University of Wisconsin, Madison
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Ludwig Institute for Cancer Research
Peter MacCallum Cancer Centre, Australia
City of Hope Medical Center
Western Sydney Local Health District
Tabriz University of Medical Sciences
Institut Bergonié
Ludwig Institute for Cancer Research
Big Ten Cancer Research Consortium
The Christie NHS Foundation Trust
Roswell Park Cancer Institute
Hoosier Cancer Research Network
Big Ten Cancer Research Consortium
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
HealthPartners Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Pittsburgh